You are here

eMOCHA ONCOGRID

Mobile and Web Application for Oral Cancer Screening in India

Indian  Sub-continent is burdened with 80% of the world’s patients with oral cancer.  Delay in diagnosis of oral cancer is one of the major problems that leads to in poor treatment outcomes (V. Shanta, R. Swaminathan, R. Rama. Cancer Control 2013). Current screening and treatment programs are not optimized to diagnose, treat and cure most patients early.  Most Indian patients live in remote, rural communities and are diagnosed only when the cancer has progressed and is difficult to treat.  The Johns Hopkins Center for Clinical Global Health Education (CCGHE) has recently launched a partnership with colleagues in India and Boston to evaluate a novel mHealth application to support the screening, referral and clinical care of patients with oral cancer.

The ONCOGRID study is led by Dr. Radhika Chigurupati, Associate Professor in the Department of Oral Maxillofacial Surgery at Boston University.  The mHealth application will leverage the eMOCHA platform, developed by the CCGHE.

Dr. Chigurupati, Dr. Moni Kuriakose from Mazumdar Shaw Cancer Center and several other partners from the dental schools in India, are about to initiate a cluster-randomized trial comparing standard screening and diagnosis of  oral cancer to an mHealth approach with a system supported by eMOCHA in 7 rural districts in Karnataka.  The goal of the study, supported by the McKesson Foundation, is to determine if mHealth support can increase diagnosis of early stage oral cancer and pre-cancer lesions  and provide access to earlier treatment.

For more information about the ONCOGRID study, please contact Dr. Chigurupati (rchiguru@bu.edu) at Boston University.

For more information about eMOCHA contact Dr. Larry Chang (larrywillchang@gmail.com) or visit CCGHE.